The Centers for Medicare & Medicaid Services’ (CMS’) final rule advances policies to promote the efficient operation of the Medicaid Drug Rebate Program (MDRP).
Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Final Rule
Newsroom Homepage
Listing of Newsroom articles
CMS Round Up
CMS Roundup (June 30, 2023)
Today, the Centers for Medicare & Medicaid Services (CMS) is providing an at-a-glance summary of news from around the agency. IRA Extends Insulin Cost Caps to Medicare Part B and Medicare Advantage Starting July 1 Starting July 1, people with Medicare Part B and Medicare Advantage coverage who get Read more about CMS Roundup (June 30, 2023)
Fact Sheets
Update: Enhancing Oncology Model Factsheet
Overview The Center for Medicare and Medicaid Innovation’s (CMMI) new, voluntary Enhancing Oncology Model (EOM) is intended to transform care for cancer patients, reduce spending, and improve quality of care. EOM is a 5-year voluntary model, beginning on July 1, 2023, that aims to improve quality Read more about Update: Enhancing Oncology Model Factsheet
Fact Sheets
Calendar Year 2024 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule (CMS-1782-P)
On June 26, 2023, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that proposes to update payment rates and policies and includes requests for information under the end-stage renal disease (ESRD) Prospective Payment System (PPS) for renal dialysis services furnished to Read more about Calendar Year 2024 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule (CMS-1782-P)
Fact Sheets
CMS announces new details of plan to cover new Alzheimer’s drugs
The Centers for Medicare & Medicaid Services (CMS) is releasing new details about how people can get drugs that may slow the progression of Alzheimer’s disease covered by Medicare. If the Food and Drug Administration (FDA) grants traditional approval, then Medicare will cover the drug in appropriate Read more about CMS announces new details of plan to cover new Alzheimer’s drugs
Fact Sheets
Notice with Comment - Transitional Coverage for Emerging Technologies (CMS-3421-NC)
The Centers for Medicare & Medicaid Services (CMS) issued a proposed procedural notice outlining a new Medicare coverage pathway to achieve more timely and predictable access to new medical technologies for people with Medicare. The new Transitional Coverage for Emerging Technologies (TCET) pathway Read more about Notice with Comment - Transitional Coverage for Emerging Technologies (CMS-3421-NC)
CMS Round Up